首页> 外国专利> DERIVATIVES OF 4-AMINOTIAZOL, ITS PREPARATION AND ITS USE AS INHIBITORS OF CYCLINE DEPENDENT KINASE

DERIVATIVES OF 4-AMINOTIAZOL, ITS PREPARATION AND ITS USE AS INHIBITORS OF CYCLINE DEPENDENT KINASE

机译:4-氨基噻唑的衍生物,其制备及其作为细胞周期蛋白依赖性激酶抑制剂的用途

摘要

A compound of Formula I: in which: R 1 is a substituted or unsubstituted group selected from C 1-6 alkyl, C 1-6 alkenyl; C1-6 alkynyl; C1-6 alkoxy, C1-6 alcohol, carbocyclic or heterocyclic, monocyclic or polycyclic condensed or non-condensed cycloalkyl, carbocyclic or heterocyclic aryl, monocyclic or non-condensed polycyclic, naphthyl, indolyl, quinolinyl, isoquinolinyl, acridinyl, benzimidazolyl, benzothiophenyl, benzothiophenyl carbonyl, ether, (C1-6 alkyl) -carbonyl, (C1-6 alkyl) aryl, (C1-6 alkyl) -cycloalkyl, (C1-6 alkyl) - (C1-6 alkoxy); aryl- (C1-6 alkoxy), thioether, thiol, and sulfonyl, where when R1 is substituted, each substituent is independently halogen, haloalkyl, C1-6 alkyl, C1-6 alkenyl, C1-6 alkynyl, hydroxyl, C1- alkoxy 6, amino, nitro, thiol, thioether, imine, cyano, amido, phosphonate, phosphine, carboxyl, thiocarbonyl, sulfonyl, sulfonamide, ketone, aldehyde, ester, oxygen, carbocyclic or heterocyclic cycloalkyl, condensed or non-condensed monocyclic or carbocyclic aryl or heterocyclic, monocyclic or condensed or non-condensed polycyclic and R2 is a condensed or non-condensed carbocyclic or heterocyclic, monocyclic or polycyclic ring structure having a substituent in the position adjacent to the junction point, whose ring structure is further optionally substituted, where each R2 substituent is independently halogen, haloalkyl, C1-6 alkyl, C1-6 alkenyl, C1-6 alkynyl, hydroxyl, C1-6 alkoxy, amino, nitro, thiol, t ioether, imine, cyano, amido, phosphonate, phosphine, carboxyl, thiocarbonyl, sulfonyl, sulfonamide, ketone, aldehyde, ester, oxygen, carbocyclic or heterocyclic, monocyclic or polycyclic condensed or non-condensed cycloalkyl or carbocyclic or heterocyclic, monocyclic or condensed monocyclic or non-condensed, or a pharmaceutically acceptable salt of a compound of Formula I, or pharmaceutically acceptable salt thereof.
机译:式I的化合物:其中:R 1为选自C 1-6烷基,C 1-6烯基的取代或未取代的基团; C 1-6炔基; C 1-6烷氧基,C 1-6醇,碳环或杂环,单环或多环稠合或非稠合的环烷基,碳环或杂环芳基,单环或非稠合多环,萘基,吲哚基,喹啉基,异喹啉基,cri啶基,苯并咪唑基,苯并噻吩基,苯甲硫基苯基羰基,醚,(C 1-6烷基)-羰基,(C 1-6烷基)芳基,(C 1-6烷基)-环烷基,(C 1-6烷基)-(C 1-6烷氧基);芳基-(C1-6烷氧基),硫醚,硫醇和磺酰基,其中当R1被取代时,每个取代基独立地是卤素,卤代烷基,C1-6烷基,C1-6烯基,C1-6炔基,羟基,C1-烷氧基6,氨基,硝基,硫醇,硫醚,亚胺,氰基,酰胺基,膦酸酯,膦,羧基,硫代羰基,磺酰基,磺酰胺,酮,醛,酯,氧,碳环或杂环环烷基,稠合或非稠合的单环或碳环芳基R 2是在与连接点相邻的位置具有取代基的取代或未取代的碳环或杂环,单环或多环的稠合或不稠合的碳环或杂环,其中R 2的环结构进一步任选地被取代,其中每个R2取代基独立地是卤素,卤代烷基,C1-6烷基,C1-6烯基,C1-6炔基,羟基,C1-6烷氧基,氨基,硝基,硫醇,硫醚,亚胺,氰基,酰胺基,膦酸酯,膦,羧基,硫代羰基,磺酰基,磺基式I化合物的酰胺,酮,醛,酯,氧,碳环或杂环,单环或多环稠合或非稠合的环烷基或碳环或杂环,单环或稠合的单环或非稠合的或药学上可接受的式I化合物的盐,或其药学上可接受的盐。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号